Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency

Arthritis and Rheumatism

Volumn 60, Issue 9, 2009, Pages 2767-2771

  Visentini, Marcella ^a   Conti, Valentina ^a   Cagliuso, Maria ^a   Tinti, Francesca ^a   Siciliano, Giulia ^a   Trombetta, Amelia C ^a   Mitterhofer, Anna Paola ^a   Fiorilli, Massimo ^a   Quinti, Isabella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN; PREDNISONE; PROTEIN INHIBITOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; DIALYSIS; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; IN VITRO STUDY; KIDNEY FAILURE; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT INFECTION; RELAPSE; REMISSION; RESPIRATORY TRACT INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY TRACT INFECTION;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; COMMON VARIABLE IMMUNODEFICIENCY; DNA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROGNOSIS; REMISSION INDUCTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 69449088671     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24760     Document Type: Article

References (16)

1. Roelofs MF, Abdollahi-Roodsaz S, Joosten LA, van den Berg WB, Radstake TR. The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions [review]. Arthritis Rheum 2008;58:338-348 (Pubitemid 351294868)
2. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Sholmchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B-cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603-607 (Pubitemid 34406754)
3. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005;202:1171-1177 (Pubitemid 41586947)
4. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005;202:321-331 (Pubitemid 41043827)
5. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006;25:417-428 (Pubitemid 44354217)
6. Haymore BR, Mikita CP, Tsokos GC. Common variable immune deficiency (CVID) presenting as an autoimmune disease: role of memory B cells. Autoimmun Rev 2008;7:309-312
7. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008;111:77-85.
8. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000;243:147-154
9. Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 2006;36:810-816
10. Fernandez-Castro M, Mellor-Pita S, Citores MJ, Munoz P, Tutor-Ureta P, Silva L, et al. Common variable immunodeficiency in systemic lupus erythematosus. Semin Arthritis Rheum 2007;36:238-245 (Pubitemid 46177203)
11. Cambridge G, Leandro MJ, Teodorescu M, Manson J, Rahman A, Isenberg DA, et al. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum 2006;54:3612-3622 (Pubitemid 44737173)
12. Herlands RA, Christensen SR, Sweet RA, Hershberg U, Shlomchik MJ. T cell-independent and Toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity 2008;29:249-260
13. Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, et al. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann Rheum Dis 2008;67:1011-1016 (Pubitemid 351956665)
14. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007;357:1903-1915
15. Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol 2006;176:1978-1987 (Pubitemid 43134344)
16. Hodgkin PD, Lee JH, Lyons AB. B cell differentiation and isotype switching is related to division cycle number. J Exp Med 1996;184:277-281 (Pubitemid 26247238)